Similar companies
| Company | Revenue | |
|---|---|---|
 |
Abbott LaboratoriesABT |
11.5B 0.8% |
 |
WaystarWAY |
304M 13% |
Income Statement (NONE)
| Q4 '25 | QoQ | |
|---|---|---|
| Revenue | 65.4B | 2.2% |
| Gross Profit | 2.21B | 4.7% |
| Cost of Revenue | 63.2B | 2.5% |
| Operating expense | 1.5B | 8.9% |
| Net Income | 471M | 4.7% |
| EBITDA | 707M | 22.4% |
Balance Sheet (NONE)
| Q4 '25 | QoQ | |
|---|---|---|
| Total Assets | 58.1B | 5.2% |
| Total Liabilities | 60.8B | 4.9% |
| Shares Outstanding | 237M | 0.8% |
Cash Flow (NONE)
| Q4 '25 | QoQ | |
|---|---|---|
| Cash from operations | 686M | 29.5% |
| Cash from investing | -1.98B | 1294.4% |
| Cash from financing | -519M | 371.8% |
EPS
Financial Highlights for Cardinal Health in Q4 '25
Cardinal Health reported a revenue of 65.4B, which is a 2.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 2.21B, marking a -4.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 63.2B, a 2.5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.5B, showing a -8.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 471M, showing a 4.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 707M, showing a -22.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Cardinal Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures. A decline in EBITDA signals potential operational challenges or increased costs.
